Factors of Influence in 2019, Key Indicators and Opportunity within Expedia Group, Lumentum, Patterson Companies, Allscripts Healthcare Solutions, AtriCure, and Biohaven Pharmaceutical Holding — New Research Emphasizes Economic Growth

Author's Avatar
Mar 05, 2019
Article's Main Image

NEW YORK, March 05, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Expedia Group, Inc. (EXPE, Financial), Lumentum Holdings Inc. (LITE, Financial), Patterson Companies, Inc. (PDCO, Financial), Allscripts Healthcare Solutions, Inc. (MDRX, Financial), AtriCure, Inc. (ATRC, Financial), and Biohaven Pharmaceutical Holding Company Ltd. (:BHVN), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

EXPE DOWNLOAD: http://MarketSourceResearch.com/register/?so=EXPE
LITE DOWNLOAD: http://MarketSourceResearch.com/register/?so=LITE
PDCO DOWNLOAD: http://MarketSourceResearch.com/register/?so=PDCO
MDRX DOWNLOAD: http://MarketSourceResearch.com/register/?so=MDRX
ATRC DOWNLOAD: http://MarketSourceResearch.com/register/?so=ATRC
BHVN DOWNLOAD: http://MarketSourceResearch.com/register/?so=BHVN

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Expedia Group, Inc. (EXPE, Financial), Lumentum Holdings Inc. (LITE, Financial), Patterson Companies, Inc. (PDCO, Financial), Allscripts Healthcare Solutions, Inc. (MDRX, Financial), AtriCure, Inc. (ATRC, Financial), and Biohaven Pharmaceutical Holding Company Ltd. (:BHVN) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 1st, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

EXPEDIA GROUP, INC. (EXPE, Financial) REPORT OVERVIEW

Expedia Group's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Expedia Group reported revenue of $2,559.00MM vs $2,319.00MM (up 10.35%) and analysts estimated basic earnings per share $0.10 vs $0.37 (down 72.97%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Expedia Group reported revenue of $11,223.00MM vs $10,060.00MM (up 11.56%) and analysts estimated basic earnings per share $2.71 vs $2.49 (up 8.84%). Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.69. The estimated EPS forecast for the next fiscal year is $7.08 and is expected to report on February 6th, 2020.

To read the full Expedia Group, Inc. (EXPE, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=EXPE

-----------------------------------------

LUMENTUM HOLDINGS INC. (LITE, Financial) REPORT OVERVIEW

Lumentum's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Lumentum reported revenue of $373.70MM vs $404.60MM (down 7.64%) and analysts estimated basic earnings per share $0.24 vs $3.21 (down 92.52%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, Lumentum reported revenue of $1,247.70MM vs $1,001.60MM (up 24.57%) and analysts estimated basic earnings per share $3.88 vs -$1.71. Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.64. The estimated EPS forecast for the next fiscal year is $4.76 and is expected to report on August 14th, 2019.

To read the full Lumentum Holdings Inc. (LITE, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=LITE

-----------------------------------------

PATTERSON COMPANIES, INC. (PDCO, Financial) REPORT OVERVIEW

Patterson Companies' Recent Financial Performance

For the three months ended October 31st, 2018 vs October 31st, 2017, Patterson Companies reported revenue of $1,404.75MM vs $1,385.74MM (up 1.37%) and analysts estimated basic earnings per share $0.31 vs $0.43 (down 27.91%). For the twelve months ended April 30th, 2018 vs April 30th, 2017, Patterson Companies reported revenue of $5,465.68MM vs $5,593.13MM (down 2.28%) and analysts estimated basic earnings per share $2.17 vs $1.80 (up 20.56%). Analysts expect earnings to be released on June 20th, 2019. The report will be for the fiscal period ending April 30th, 2019. Reported EPS for the same quarter last year was $0.30. The estimated EPS forecast for the next fiscal year is $1.53 and is expected to report on June 20th, 2019.

To read the full Patterson Companies, Inc. (PDCO, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=PDCO

-----------------------------------------

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX, Financial) REPORT OVERVIEW

Allscripts Healthcare Solutions' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Allscripts Healthcare Solutions reported revenue of $522.28MM vs $449.44MM (up 16.21%) and basic earnings per share -$0.20 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Allscripts Healthcare Solutions reported revenue of $1,806.34MM vs $1,549.90MM (up 16.55%) and analysts estimated basic earnings per share -$1.09 vs -$0.14. Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.11. The estimated EPS forecast for the next fiscal year is $0.56 and is expected to report on February 20th, 2020.

To read the full Allscripts Healthcare Solutions, Inc. (MDRX, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=MDRX

-----------------------------------------

ATRICURE, INC. (ATRC, Financial) REPORT OVERVIEW

AtriCure's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, AtriCure reported revenue of $49.94MM vs $42.15MM (up 18.48%) and analysts estimated basic earnings per share -$0.22 vs -$0.22. For the twelve months ended December 31st, 2017 vs December 31st, 2016, AtriCure reported revenue of $174.72MM vs $155.11MM (up 12.64%) and analysts estimated basic earnings per share -$0.83 vs -$1.05. Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.31. The estimated EPS forecast for the next fiscal year is -$0.25 and is expected to report on February 27th, 2020.

To read the full AtriCure, Inc. (ATRC, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=ATRC

-----------------------------------------

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. (BHVN, Financial) REPORT OVERVIEW

Biohaven Pharmaceutical Holding's Recent Financial Performance

Analysts expect earnings to be released on May 21st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$2.32. The estimated EPS forecast for the next fiscal year is -$4.81 and is expected to report on February 27th, 2020.

To read the full Biohaven Pharmaceutical Holding Company Ltd. (BHVN, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=BHVN

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: [email protected]

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

ti?nf=NzU1Mzc0NyMyODEwMTE3IzUwMDAzMTMyNg==